Literature DB >> 28667371

Surface Engineered Ho3+ Incorporated Fluorescent Dye-Doped Bifunctional Silica Nanoparticles for Receptor Targeted Fluorescence Imaging and Potential Magnetic Resonance Imaging.

Sasidharanpillai S Syamchand1, Ravindran S Aparna1, Sony George2.   

Abstract

The authors report Ho3+ ion incorporated and fluorescent dye-doped silica nanoparticles which are engineered to enable the imaging modalities of receptor targeted fluorescence imaging (FI) and magnetic resonance imaging (MRI). The silica nanoparticles synthesized through a modified Stöber method is luminomagnetic by virtue of the luminescence of organic dye fluorophore (FITC) and magnetism of Ho3+. The doping concentration of Ho3+ is estimated by inductively coupled plasma mass spectrometry (ICP-MS) as 0.97%. The presence of Ho3+ has a little effect on the luminescence intensity but impart strong paramagnetism of 27.217 emu/g at room temperature. The relaxivity measurements shown that the nanoparticles exhibit a longitudinal relaxivity (r1) of 0.12 s-1 mM-1 and transverse relaxivity (r2) of 26.96 s-1 mM-1, which makes the system potentially suitable for developing T2 MRI contrast agents based on holmium. The luminomagnetic nanoparticles were surface engineered through aminization and conjugated with folic acid (FA) to address the folate receptor targeted imaging of the cancer cells. The biocompatibility studies revealed no apparent toxicity even at higher doses of 750 μg/mL and at 48 h of incubation. The as prepared nanoparticles were demonstrated as a bioimaging probe in the in vitro receptor targeted fluorescence imaging of HeLa cells. The luminescence and magnetism together with biocompatibility enables the adaptability of the present system as a nano platform for potential bimodal imaging. Graphical Abstract ᅟ.

Entities:  

Keywords:  FITC; Fluorescence imaging; Holmium; Luminomagnetic silica nanoparticles; MRI; Receptor targeted imaging; T2 contrast agents

Mesh:

Substances:

Year:  2017        PMID: 28667371     DOI: 10.1007/s10895-017-2128-9

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  29 in total

1.  Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.

Authors:  Yu Gao; Yu Chen; Xiufeng Ji; Xinyu He; Qi Yin; Zhiwen Zhang; Jianlin Shi; Yaping Li
Journal:  ACS Nano       Date:  2011-11-16       Impact factor: 15.881

2.  Fluorescent dye-doped silica nanoparticles: new tools for bioapplications.

Authors:  Se Won Bae; Weihong Tan; Jong-In Hong
Journal:  Chem Commun (Camb)       Date:  2012-01-18       Impact factor: 6.222

3.  Sensitization of near-infrared-emitting lanthanide cations in solution by tropolonate ligands.

Authors:  Jian Zhang; Paul D Badger; Steven J Geib; Stéphane Petoud
Journal:  Angew Chem Int Ed Engl       Date:  2005-04-22       Impact factor: 15.336

4.  A facile synthesis, in vitro and in vivo MR studies of d-glucuronic acid-coated ultrasmall Ln₂O₃ (Ln = Eu, Gd, Dy, Ho, and Er) nanoparticles as a new potential MRI contrast agent.

Authors:  Krishna Kattel; Ja Young Park; Wenlong Xu; Han Gyeol Kim; Eun Jung Lee; Badrul Alam Bony; Woo Choul Heo; Jae Jun Lee; Seonguk Jin; Jong Su Baeck; Yongmin Chang; Tae Jeong Kim; Ji Eun Bae; Kwon Seok Chae; Gang Ho Lee
Journal:  ACS Appl Mater Interfaces       Date:  2011-09-01       Impact factor: 9.229

Review 5.  MRI contrast agents based on dysprosium or holmium.

Authors:  Małgorzata Norek; Joop A Peters
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2010-09-07       Impact factor: 9.795

6.  TAT conjugated, FITC doped silica nanoparticles for bioimaging applications.

Authors:  Swadeshmukul Santra; Heesun Yang; Debamitra Dutta; Jessie T Stanley; Paul H Holloway; Weihong Tan; Brij M Moudgil; Robert A Mericle
Journal:  Chem Commun (Camb)       Date:  2004-10-25       Impact factor: 6.222

7.  Measuring the fluorescent quantum efficiency of indocyanine green encapsulated in nanocomposite particulates.

Authors:  T J Russin; E İ Altınoğlu; J H Adair; P C Eklund
Journal:  J Phys Condens Matter       Date:  2010-08-04       Impact factor: 2.333

8.  Folic acid as delivery vehicles: targeting folate conjugated fluorescent nanoparticles to tumors imaging.

Authors:  Jun Ai; Yuanhong Xu; Dan Li; Zuojia Liu; Erkang Wang
Journal:  Talanta       Date:  2012-09-12       Impact factor: 6.057

9.  A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent.

Authors:  Anusha Ashokan; Deepthy Menon; Shantikumar Nair; Manzoor Koyakutty
Journal:  Biomaterials       Date:  2009-12-24       Impact factor: 12.479

10.  Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy.

Authors:  Feng Chen; Hao Hong; Sixiang Shi; Shreya Goel; Hector F Valdovinos; Reinier Hernandez; Charles P Theuer; Todd E Barnhart; Weibo Cai
Journal:  Sci Rep       Date:  2014-05-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.